通过F13A1介导的巨细胞激活,通过PKM2/HIF1A通路促进MASH的进展
Qianrang Lu1,2, Meiching Ong1,2, Xuewen Yi1,2
1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 19, 2025
概括
凝血因子XIII-A (F13A1) 阳性巨细胞在代谢相关脂肪肝炎 (MASH) 中驱动炎症. 准F13A1/PKM2/HIF1A通路为MASH提供了一个新的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 巨细胞是MASH肝炎和纤维化中的关键参与者.
- 在MASH中巨细胞激活的机制尚未完全理解.
研究的目的:
- 确定MASH肝脏中占主导地位的巨细胞子集.
- 阐明驱动MASH相关巨细胞激活的分子机制.
- 调查F13A1作为潜在的治疗点.
主要方法:
- 对人类MASH肝脏的单核转录组分析.
- 在患者样本和小鼠模型中进行验证.
- 在体内基因沉默和药理干预.
- 生物化学试验用于研究蛋白质相互作用和代谢重编程.
主要成果:
- 阳性F13A1巨细胞是MASH肝脏中占主导地位的子集.
- 脂质压力肝细胞通过S1P信号诱导F13A1.
- F13A1沉默可以减少炎症和肝损伤.
- F13A1与PKM2相互作用,通过PKM2/HIF1A轴促进二分化和IL1B上调.
- F13A1增强了巨细胞中的华堡效应.
- 通过DASA-58激活PKM2,可以抑制F13A1驱动的炎症.
结论:
- 在MASH中,F13A1是巨细胞介导炎症的关键驱动因素.
- F13A1/PKM2/HIF1A通路是MASH的一个有前途的治疗点.
- 药理学向PKM2表明了治疗潜力.
相关概念视频
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K


